
Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation
Author(s) -
Anne Ward,
Jason R. Hollister,
Young Pyo Choi,
Brent Race,
Katie Williams,
Daniel Shoup,
Roger A. Moore,
Suzette A. Priola
Publication year - 2019
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0219457
Subject(s) - protease , biology , virology , scrapie , epitope , glycoprotein , inoculation , prion protein , microbiology and biotechnology , antibody , immunology , pathology , enzyme , medicine , biochemistry , disease
Prion protein (PrP C ) is a protease-sensitive and soluble cell surface glycoprotein expressed in almost all mammalian cell types. PrP Sc , a protease-resistant and insoluble form of PrP C , is the causative agent of prion diseases, fatal and transmissible neurogenerative diseases of mammals. Prion infection is initiated via either ingestion or inoculation of PrP Sc or when host PrP C stochastically refolds into PrP Sc . In either instance, the early events that occur during prion infection remain poorly understood. We have used transgenic mice expressing mouse PrP C tagged with a unique antibody epitope to monitor the response of host PrP C to prion inoculation. Following intracranial inoculation of either prion-infected or uninfected brain homogenate, we show that host PrP C can accumulate both intra-axonally and within the myelin membrane of axons suggesting that it may play a role in axonal loss following brain injury. Moreover, in response to the inoculation host PrP C exhibits an increased insolubility and protease resistance similar to that of PrP Sc , even in the absence of infectious prions. Thus, our results raise the possibility that damage to the brain may be one trigger by which PrP C stochastically refolds into pathogenic PrP Sc leading to productive prion infection.